Infection with dengue viruses continues to present a major public health problem (7) . The World Health Organization has targeted dengue viruses for intensive work toward vaccine development (2) . A major concern has been to prevent the occurrence of severe complications, such as hemorrhage or shock, which have been reported to be related to the presence of preexisting immunity to a heterologous dengue virus serotype (3, 8, 20) . This unusual phenomenon has been speculated to be due to antibodydependent enhancement of infection of Fc receptor-bearing cells such as monocytes based on in vitro studies (9) . A role for T cells has also been postulated, as, for example, in the immune elimination of infected monocytes (6) and in elaboration of gamma interferon, which can further augment the antibody-dependent enhancement of infection (12) .
There have been few studies of the T-lymphocyte responses to dengue virus. Previous studies with human lymphocytes in our laboratory have shown that a population of CD4+ T cells from dengue virus-immune individuals can proliferate after exposure to dengue virus antigens and that these cells produce gamma interferon when stimulated (14) . However, these studies are limited by the long interval between natural dengue virus infection and our testing and by the inability to define previous natural exposure to dengue virus and other flaviviruses that might alter the immune responses. The study of cellular immune responses to dengue virus in laboratory animals obviates some of these concerns.
Defining the dengue virus epitopes that might be involved in protection or immunopathological phenomena or both is desirable for future vaccine development. We have begun to study the murine T-lymphocyte responses to dengue virus and to viral proteins in order to identify such epitopes. We report here the characterization of an in vitro proliferative response to dengue virus antigens following immunization * (13) . Culture supernatants were collected 7 days after infection; they had titers of 106 to 107 PFU/ml and were stored at -70°C.
Vero cell-derived dengue virus antigens. Dengue virus antigens were produced as previously described (14) . Vero cells were grown to confluence and infected with dengue viruses at an approximate multiplicity of infection of 1 were cultured with various dilutions of antigen in 0.1 ml of RPMI 1640 medium supplemented with glutamine (2 mM), 100 U of penicillin per ml, 100 ,ug of streptomycin per ml, 2-mercaptoethanol (5 x 10-' M; Sigma Diagnostics, Sterling, Va.), and 1% BALB/c mouse serum (Biotrol, Inc., Indianapolis, Ind.) in 96-well round-bottom plates (Costar, Cambridge, Mass.). After 3 days of incubation at 37°C, the culture medium was changed as follows. For most experiments, 0.1 ml of RPMI 1640 supplemented with 5% fetal bovine serum (Hyclone Laboratories, Inc., Logan, Utah) was added to all wells. Cells were suspended by repeated up-and-down pipetting, and 0.1 ml of the contents of each well was transferred to a second 96-well round-bottom plate containing 0.1 ml of RPMI 1640 with 5% fetal bovine serum per well. Plates were incubated for two more days. Then the cells were pulsed with 1.25 recombinant baculovirus expressing dengue 4 virus C, pre-M, E, NS1, and NS2a proteins (Fig. 4a) . The T-cell responses were specific for the dengue 4 virus proteins expressed, e.g., the stimulation index was 7.8 (at an antigen dilution of 1:2,560) compared with the control preparation of wild-type baculovirus-infected Sf9 cells. Spleen cells from nonimmune mice did not show a dengue virus-specific response (Fig. 4a) .
We also detected dengue virus-specific stimulation by dengue 4 virus E protein alone using a recombinant baculovirus containing a shorter dengue 4 virus genome sequence (Fig. 4b) . The response to the E protein-containing preparation was lower than the response to the preparation containing multiple dengue 4 virus proteins. Nonimmune mice did not show a response to this subunit preparation (data not shown).
DISCUSSION
We demonstrated the presence of dengue virus-specific memory T lymphocytes following immunization with a single dose of live dengue virus. We used a modification of the usual lymphocyte proliferation assay to provide a superior signal-to-noise ratio by diminishing the level of nonspecific proliferation. Preliminary studies had shown that the method used in these experiments was optimal for revealing dengue virus-specific lymphoproliferative responses (A. L. Rothman, I. Kurane, and F. A. Ennis, manuscript in preparation).
We found the predominant proliferating population of lymphocytes to be Thyl+ L3T4+ Lyt2-cells. However, we cannot exclude the presence of some dengue virus-specific Lyt2+ cytotoxic T cells. We used inactivated cell-associated viral antigen as a stimulus, which may preferentially induce the proliferation of L3T4+ cells (17 (18) . Alternatively, these cells may provide help for antibody production or the generation of cytotoxic T cells and produce gamma interferon, which may increase the number of dengue virus-infected Fc receptor-bearing cells and contribute to the immunopathological processes which have been observed during secondary dengue virus infections (12, 14) .
We observed that the memory T-cell responses after primary infection with dengue viruses are directed predominantly at serotype-specific determinants. We detected some cross-reactive responses to other dengue virus serotypes and to yellow fever virus, generally in those animals which showed the highest levels of proliferation in response to the homologous serotype. These cross-reactive responses were generally only 25 to 30% as strong as the response to the homologous serotype. We did detect a high level of crossreactive response to dengue 2 virus antigen in dengue 4 virus-immune mice, although there was no reciprocal level of cross-reactivity in dengue 2 virus-immune mice. This might be explained partly by the higher viral content in our dengue 2 virus antigen or may indicate homology in the T-cell epitopes of these two dengue virus serotypes. A previous study on the delayed-type hypersensitivity response to dengue 4 virus in mice had also noted a predominantly serotype-specific response, with some cross-reactivity to dengue 2 and dengue 1 viruses (19) .
Our studies with human lymphocytes have shown a greater degree of cross-reactivity of the proliferative response among the four dengue virus serotypes (14) . This difference may be due to the fact that some of the individuals we studied had been immunized previously with yellow fever virus vaccine or had experienced more than one natural flavivirus infection, which might have augmented their cross-reactive T-lymphocyte clones.
Uren et al. (22) have reported cross-reactive proliferation of murine L3T4+ T-cell clones among the Kunjin, West Nile, and Murray Valley encephalitis flaviviruses. Several differences between that study and ours may explain the difference in findings. They used C57BL/6J (H-2b) mice and stimulated spleen cells with UV-irradiated mouse brain homogenates. Furthermore, they report results for T-cell clones isolated after repeated in vitro restimulation with antigen. Such manipulation might favor the growth of a cross-reactive T-cell population. We are establishing T-cell clones to further define the specificity of murine lymphocytes to dengue virus.
It should be noted that our finding of relative serotype specificity of the lymphocyte response is confined to the L3T4+ Lyt2-population that responded in our system. It is plausible that an L3T4-Lyt2+ lymphocyte population might respond to serotype-cross-reactive epitopes and might be capable of lysing infected monocytes during secondary dengue virus infections. Another possibility is that glutaraldehyde fixation, employed in preparation of our dengue virus antigen preparation, selectively altered cross-reactive epitopes. However, we have not seen a higher level of cross-reactivity in experiments with infectious cell-free virus preparations (A. L. Rothman, I. Kurane, and F. A. Ennis, unpublished observations). It is also conceivable that virus strains associated with a higher incidence of hemorrhagic fever or shock might be more cross-reactive. Morens and Halstead (16) (11) . Antibody directed against shared epitopes on the E glycoprotein protected against challenge with yellow fever virus as well (1). However, anti-E antibodies can enhance infection of Fc receptor-bearing cells in vitro at higher dilutions (10) , and immunization with dengue 2 virus E protein expressed by a recombinant vaccinia virus failed to protect monkeys against virus challenge (5) . Therefore, the E protein might not be ideal for vaccine development.
Schlesinger et al. (21) have demonstrated that immunization of mice with the NS1 glycoprotein of dengue 2 virus induced protection against later intracerebral challenge. Immunization did not result in the development of antibodies to structural proteins, making it unlikely that enhancement of subsequent infection would occur. Although the NS1 protein is highly conserved among flaviviruses (15) and the antibody response to NS1 immunization was cross-reactive in complement fixation assays, cross-protection against a subsequent challenge with dengue 1 virus was not seen (21) . We postulate that a failure to stimulate cross-reactive memory T lymphocytes may explain this shortcoming. We will test this possibility using purified or recombinant NS1 protein in experiments employing the same approaches reported here.
Future studies will be directed toward examining the effector functions of the memory T-lymphocyte population, including a search for their possible cytotoxic role. In addition, other recombinant viruses expressing structural and nonstructural dengue virus proteins will be used to identify the location of the predominant T-cell epitopes which may be involved in protective or immunopathological functions.
